Avantor, Inc. Increase (Decrease) in Accounts Payable, Trade
Avantor, Inc. (AVTR) reported Increase (Decrease) in Accounts Payable, Trade of $5.40 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-04-29
- Avantor, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $5.40M, a 34.15% decline year-over-year.
- Avantor, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $46.80M, a 164.41% increase year-over-year.
- Avantor, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was -$23.50M.
- Avantor, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-06-30 was $10.90M, a 87.82% decline year-over-year.
- Avantor, Inc. increase (decrease) in accounts payable, trade for fiscal 2025 was $42.40M, a 28.86% decline from fiscal 2024.
- Avantor, Inc. increase (decrease) in accounts payable, trade for fiscal 2024 was $59.60M.
- Avantor, Inc. increase (decrease) in accounts payable, trade for fiscal 2023 was -$139.60M, a 994.87% decline from fiscal 2022.
- Avantor, Inc. increase (decrease) in accounts payable, trade for fiscal 2022 was $15.60M, a 75.96% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 6 month as first filed | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 9 month as first filed | Increase (Decrease) in Accounts Payable, Trade 12 month | Increase (Decrease) in Accounts Payable, Trade 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $5.40M 10-Q · filed 2026-04-29 | $52.20M derived: sum of 2 quarters · filed 2026-04-29 | $28.70M derived: sum of 3 quarters · filed 2026-04-29 | $39.60M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-12-31 | $46.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $23.30M derived: sum of 2 quarters · filed 2026-02-11 | $34.20M derived: sum of 3 quarters · filed 2026-02-11 | $42.40M 10-K · filed 2026-02-11 | |||
| 2025-09-30 | -$23.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$12.60M derived: sum of 2 quarters · filed 2025-10-29 | -$4.40M 10-Q · filed 2025-10-29 | $13.30M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-06-30 | $10.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $19.10M 10-Q · filed 2025-08-01 | $36.80M derived: sum of 3 quarters · filed 2026-04-29 | $32.80M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-03-31 | $8.20M 10-Q · filed 2026-04-29 | $25.90M derived: sum of 2 quarters · filed 2026-04-29 | $21.90M derived: sum of 3 quarters · filed 2026-04-29 | $111.40M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2024-12-31 | $17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $13.70M derived: sum of 2 quarters · filed 2026-02-11 | $103.20M derived: sum of 3 quarters · filed 2026-02-11 | $59.60M 10-K · filed 2026-02-11 | |||
| 2024-09-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $85.50M derived: sum of 2 quarters · filed 2025-10-29 | $41.90M 10-Q · filed 2025-10-29 | -$1.90M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-06-30 | $89.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $45.90M 10-Q · filed 2025-08-01 | $2.10M derived: sum of 3 quarters · filed 2026-02-11 | -$19.30M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-03-31 | -$43.60M 10-Q · filed 2025-04-25 | -$87.40M derived: sum of 2 quarters · filed 2026-02-11 | -$108.80M derived: sum of 3 quarters · filed 2026-02-11 | -$183.80M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2023-12-31 | -$43.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$65.20M derived: sum of 2 quarters · filed 2026-02-11 | -$140.20M derived: sum of 3 quarters · filed 2026-02-11 | -$139.60M 10-K · filed 2026-02-11 | |||
| 2023-09-30 | -$21.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | -$96.40M derived: sum of 2 quarters · filed 2024-10-25 | -$95.80M 10-Q · filed 2024-10-25 | -$145.30M derived: sum of 4 quarters · filed 2025-02-07 | |||
| 2023-06-30 | -$75.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | -$74.40M 10-Q · filed 2024-07-26 | -$123.90M derived: sum of 3 quarters · filed 2025-02-07 | -$131.20M derived: sum of 4 quarters · filed 2025-02-07 | |||
| 2023-03-31 | $600.00K 10-Q · filed 2024-04-26 | -$48.90M derived: sum of 2 quarters · filed 2025-02-07 | -$56.20M derived: sum of 3 quarters · filed 2025-02-07 | -$57.00M derived: sum of 4 quarters · filed 2025-02-07 | |||
| 2022-12-31 | -$49.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | -$56.80M derived: sum of 2 quarters · filed 2025-02-07 | -$57.60M derived: sum of 3 quarters · filed 2025-02-07 | $15.60M 10-K · filed 2025-02-07 | |||
| 2022-09-30 | -$7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$8.10M derived: sum of 2 quarters · filed 2023-10-27 | $65.10M 10-Q · filed 2023-10-27 | $128.10M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-06-30 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $72.40M 10-Q · filed 2023-07-28 | $135.40M derived: sum of 3 quarters · filed 2024-02-14 | $74.20M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-03-31 | $73.20M 10-Q · filed 2023-04-28 | $136.20M derived: sum of 2 quarters · filed 2024-02-14 | $75.00M derived: sum of 3 quarters · filed 2024-02-14 | $107.80M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2021-12-31 | $63.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $1.80M derived: sum of 2 quarters · filed 2024-02-14 | $34.60M derived: sum of 3 quarters · filed 2024-02-14 | $64.90M 10-K · filed 2024-02-14 | |||
| 2021-09-30 | -$61.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$28.40M derived: sum of 2 quarters · filed 2022-10-28 | $1.90M 10-Q · filed 2022-10-28 | $44.70M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-06-30 | $32.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $63.10M 10-Q · filed 2022-07-29 | $105.90M derived: sum of 3 quarters · filed 2023-02-14 | $142.60M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-03-31 | $30.30M 10-Q · filed 2022-04-29 | $73.10M derived: sum of 2 quarters · filed 2023-02-14 | $109.80M derived: sum of 3 quarters · filed 2023-02-14 | $73.90M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2020-12-31 | $42.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $79.50M derived: sum of 2 quarters · filed 2023-02-14 | $43.60M derived: sum of 3 quarters · filed 2023-02-14 | $110.60M 10-K · filed 2023-02-14 | |||
| 2020-09-30 | $36.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $800.00K derived: sum of 2 quarters · filed 2021-10-29 | $67.80M 10-Q · filed 2021-10-29 | $54.10M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2020-06-30 | -$35.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $31.10M 10-Q · filed 2021-07-30 | $17.40M derived: sum of 3 quarters · filed 2022-02-11 | $5.70M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2020-03-31 | $67.00M 10-Q · filed 2021-04-28 | $53.30M derived: sum of 2 quarters · filed 2022-02-11 | $41.60M derived: sum of 3 quarters · filed 2022-02-11 | $59.60M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2019-12-31 | -$13.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$25.40M derived: sum of 2 quarters · filed 2022-02-11 | -$7.40M derived: sum of 3 quarters · filed 2022-02-11 | -$2.00M 10-K · filed 2022-02-11 | $5.10M 10-K · filed 2020-02-14 | ||
| 2019-09-30 | -$11.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $6.30M derived: sum of 2 quarters · filed 2020-10-27 | $11.70M 10-Q · filed 2020-10-27 | $7.90M 10-Q · filed 2019-11-05 | $74.00M derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $23.40M 10-Q · filed 2020-07-29 | $21.70M 10-Q · filed 2019-08-06 | $85.70M derived: sum of 3 quarters · filed 2021-02-16 | $39.60M derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-03-31 | $5.40M 10-Q · filed 2020-04-29 | $67.70M derived: sum of 2 quarters · filed 2021-02-16 | $21.60M derived: sum of 3 quarters · filed 2021-02-16 | ||||
| 2018-12-31 | $62.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $16.20M derived: sum of 2 quarters · filed 2021-02-16 | $34.20M 10-K · filed 2021-02-16 | $29.40M 10-K · filed 2020-02-14 | |||
| 2018-09-30 | -$46.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$28.10M 10-Q · filed 2019-11-05 | |||||
| 2018-06-30 | $18.00M 10-Q · filed 2019-08-06 | ||||||
| 2017-12-31 | $31.80M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |